Morgan G. Mathieu - Concepedia

Author

Morgan G. Mathieu

Nottingham Trent University

Also Known As

M G Mathieu, M. Mathieu, Mathieu, M, Morgan G Mathieu, Morgan G. Mathieu, Morgan Mathieu

Publications

257

Citations

H-Index

Concepts

All Affiliations

Nottingham Trent University

About

Morgan G. Mathieu is an author at Nottingham Trent University specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	107
2	Immunology	4	4	107
3	Cell Biology	2	2	72
4	Pathology	2	2	49
5	Allergy	1	1	25

Morgan G. Mathieu

Publications

205

Citations

H-Index

Page 1

	Year	Citations
A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics Naomi Harner-Foreman, Jayakumar Vadakekolathu, Stéphanie A. Laversin, Scientific Reports	2017	45
HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers. Morgan G. Mathieu, Adam J. Linley, Stephen Reeder, PubMed Hage ExpressionImmunocytochemical TechniqueImmunologyPathologyHage Protein	2010	39
The Helicase HAGE Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Cell Proliferation in Vivo Adam J. Linley, Morgan G. Mathieu, Amanda K. Miles, Journal of Biological Chemistry	2012	34
Novel prostate acid phosphatase‐based peptide vaccination strategy induces antigen‐specific <scp>T</scp>‐cell responses and limits tumour growth in mice Jaimy Saif, Jayakumar Vadakekolathu, Shraddha S. Rane, European Journal of Immunology ImmunologyAntigen ProcessingPeptide ScienceImmunotherapeuticsImmunotherapy	2013	33
HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides Morgan G. Mathieu, Ashley Knights, Graham Pawelec, Cancer Immunology Immunotherapy HistocompatibilityCancer/testis AntigenCancer ImmunosurveillanceAllergyAutoimmune Disease	2007	25
The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1 Morgan G. Mathieu, Amanda K. Miles, Murrium Ahmad, Cell Death and Disease	2014	19
Cancer/testis antigens for therapeutic use. Morgan G. Mathieu, Amanda K. Miles, G Li, PubMed ImmunologyImmunoeditingPathologyImmunotherapeuticsImmunotherapy	2009	10

Page 1